MilliporeSigma Capacity Update May 2024: Small Molecule APl and HPAPI Development
Source: MilliporeSigma
MilliporeSigma's small molecule API CDMO team has the expertise, experience, and specialized facilities to make our customers' small molecule API projects a success. With open capacity at multiple scales and a world class development team, we are committed to providing you with your clinical batch within 9 months of project start. Whether your API is a complex API, an HPAPI, a TPD, a linker payload, or a small molecule conjugate, MilliporeSigma is ready to tackle the most difficult challenges in order to accelerate your small molecule program.
access the Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.
Subscribe to Pharmaceutical Online
X
Subscribe to Pharmaceutical Online
MilliporeSigma
This website uses cookies to ensure you get the best experience on our website. Learn more